Tirzepatide Cost in 2026: Brand vs. Compounded, With & Without Insurance

In 2026, the manufacturer's list price for brand-name Zepbound (tirzepatide) is about $1,086 a month for a 28-day supply. Most people don't pay full sticker, but what you actually pay depends on how you buy it and whether insurance covers weight loss at all. Elara's compounded tirzepatide program starts at $355 a month, all-inclusive, and drops to about $298 a month on the 12-month plan. Here's the real math, without the fine print.

Key takeaways

• Brand Zepbound's list price is about $1,086/month (four pens, a 28-day supply). Eli Lilly's self-pay pharmacy, LillyDirect, sells the medication for roughly $299-$449/month depending on the dose.
• Elara's compounded tirzepatide starts at $355/month and includes the provider visit, the medication, shipping, ongoing support from the medical team, and the app.
• Compounded medications are not FDA-approved. Brand Zepbound is FDA-approved for chronic weight management. These are different products, see below.
• Tirzepatide generally costs more than semaglutide at every tier, including at Elara ($355 vs. $247 to start). It's a newer, dual-action molecule.
• Insurance often doesn't cover tirzepatide for weight loss. With commercial coverage plus Lilly's savings card, eligible patients may pay as little as $25/month, but many plans exclude it entirely. Elara is cash-pay, so there's nothing to pre-authorize.

How much does tirzepatide cost per month in 2026?

There are four common ways to pay for tirzepatide, and the real-world price ranges from about $25 to about $1,086 a month depending on which one fits you.

A few notes on that table. The $1,086 list price is the sticker price Lilly publishes for a 28-day supply of four pens across every dose strength; almost no one pays it directly. Through LillyDirect self-pay, Lilly sells the medication for about $299/month (2.5 mg), $399/month (5 mg), and $449/month (7.5 mg and higher), but that covers the medication only, and you still need a prescription and a provider. If you have commercial insurance that covers Zepbound, Lilly's savings card can bring your share down to as little as $25/month. Elara's compounded tirzepatide is a different product at a different price point, and the number you see is genuinely all-in.

One naming point, because it trips people up: Zepbound and Mounjaro both contain tirzepatide, but they're approved for different things. Zepbound is FDA-approved for chronic weight management. Mounjaro is FDA-approved for type 2 diabetes, and using it for weight loss is off-label. When we talk about brand tirzepatide for weight loss, Zepbound is the product that carries that approval.

Brand vs. compounded: what you're actually comparing

Be clear-eyed here, because it's the part most price comparisons blur. Brand Zepbound and compounded tirzepatide are not the same product.

Zepbound is the FDA-approved, brand-name finished drug, tested and approved for chronic weight management in adults who meet the criteria. Compounded tirzepatide is prepared by a state-licensed compounding pharmacy and prescribed by a licensed clinician when it's appropriate for you. It is not the branded drug, and it is not FDA-approved.

About compounded medications: Compounded semaglutide and tirzepatide are prepared by a state-licensed compounding pharmacy and prescribed by a licensed clinician when appropriate for you. Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. They are not "generic" versions of Ozempic®, Wegovy®, Mounjaro®, or Zepbound®. Talk to a licensed clinician about whether a compounded or FDA-approved option is right for you.

So the honest comparison isn't "the same thing for less." It's a comparison of price and access: brand Zepbound lists around $1,086 a month; Elara's compounded tirzepatide program starts at $355 a month, all-in. You weigh that difference against the fact that the compounded product is not FDA-approved, and a licensed provider helps you decide what fits your situation and your health history.

What does "all-inclusive" mean at Elara, and what hidden fees should you check for elsewhere?

At Elara, one price covers everything: the provider visit, the medication, shipping to your door, ongoing access to the medical team after your prescription, the private community, and the app. There is no separate membership fee.

Here are Elara's compounded tirzepatide plans:

The longer plans lower the monthly cost because they're billed up front, the same medication and care, spread across more months.

When you shop around, the headline number is rarely the whole number. Before you compare prices anywhere, ask whether the quote includes:

• The provider visit / consultation, some services bill this separately.
• The medication at every dose, some prices climb as your dose is titrated up over the weeks.
• Shipping, often added at checkout.
• A membership or subscription fee stacked on top of the medication.
• Lab work, if it's required.
• Follow-ups and messaging with the medical team.
• Cancellation or restart fees.

That checklist isn't hypothetical. In December 2025, the FTC finalized an order against telehealth GLP-1 seller NextMed over an advertised monthly price that didn't include the drug, the required lab work, or the provider consultation, plus undisclosed one-year commitments and early-termination fees. The order set aside money for consumer refunds. Hidden fees are exactly what "all-inclusive" is meant to prevent.

Why is tirzepatide more expensive than semaglutide?

Because it's a different, newer medicine, not because one is "better value" than the other in a simple way. Tirzepatide is a dual-action molecule that works on two gut-hormone pathways (GIP and GLP-1), while semaglutide works on one (GLP-1). That difference shows up in the price at essentially every tier:

• Brand: Zepbound lists around $1,086/month; the brand semaglutide products sit in a similar four-figure range.
• At Elara: compounded tirzepatide starts at $355/month, versus $247/month for compounded semaglutide.

So if budget is the deciding factor, semaglutide is the lower-cost starting point; if your provider is weighing the newer dual-action option, tirzepatide costs more. Neither choice is "the same drug for less", they're different molecules, and which one suits you is a clinical decision, not just a price one. You can see the semaglutide side of this in our semaglutide cost breakdown.

One thing you may have read that's now out of date: that compounded tirzepatide is widely available "because of a shortage." The FDA declared the tirzepatide shortage resolved in December 2024, and mass shortage-based compounding wound down in 2025. Today, narrow, patient-specific compounding under section 503A continues where a licensed clinician documents a clinical need for you individually. (Separately, in April 2026 the FDA proposed excluding tirzepatide from the 503B "bulks" list used by large outsourcing facilities; the comment period was extended to July 30, 2026. That's a proposal, not a final rule, this area is still moving, so we keep this page dated.)

Does insurance cover tirzepatide for weight loss?

Sometimes, but often not, and rarely without hoops. Coverage for tirzepatide prescribed specifically for weight loss is inconsistent: many commercial plans exclude anti-obesity medications, and traditional Medicare has generally not covered drugs prescribed for weight alone. When a plan does cover Zepbound, Lilly's savings card can lower an eligible commercial patient's cost to as little as $25/month, but you usually have to clear prior authorization or step therapy first, and it's common for a plan to cover tirzepatide for diabetes while excluding the same molecule for weight management. Always check your specific plan.

This is where cash-pay is a feature, not a compromise. With Elara, there's nothing to pre-authorize, no coverage to verify, and no denial to appeal. You know the price up front, and it doesn't change based on what an insurer decides. For a lot of women, especially anyone who's already been denied coverage for a weight-management drug, that predictability is the point.

Is compounded tirzepatide safe, and is the lower price legitimate?

Lower cost and "legit" are not opposites, but how it's provided is what matters. Legitimate care means a licensed provider reviews every patient, the medication comes from a US state-licensed pharmacy, pricing is transparent and all-in, and you have real human support and clear safety information. Red flags to walk away from: "no prescription needed," no way to reach a provider, "research use only" products, miracle promises, or fees that appear after you've paid.

Because this is a prescription medication, the safety basics apply no matter where you get it or what it costs:

Safety note. Tirzepatide carries a boxed warning for the risk of thyroid C-cell tumors. It is contraindicated if you or a family member have had medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Other important cautions include pancreatitis, gallbladder problems, and significant gastrointestinal side effects. Tirzepatide can also make oral birth control less effective, and GLP-1 medicines are not recommended in pregnancy or while breastfeeding. This is not the full list, review the FDA prescribing information and talk to a licensed provider about whether tirzepatide is right for you.

How Elara helps

If price transparency is what you're after, that's the whole idea behind how Elara prices its program. Compounded tirzepatide starts at $355/month, all-in, the provider visit, the medication, shipping, ongoing access to the medical team, and the app, with no separate membership fee, and it drops to about $298/month on the 12-month plan. A licensed provider reviews every patient (synchronously or asynchronously depending on your state and case), Elara serves all 50 states plus Puerto Rico, and support is available 7 days a week.

**See Elara's compounded tirzepatide plans, from $355/month, all-in.** Or take the free eligibility check; a licensed provider reviews every patient. Compounded medications are not FDA-approved.

For the fuller picture, compare the numbers for the other molecule in our semaglutide cost breakdown, learn what to look for when buying GLP-1s online, and read the current legal status of compounded GLP-1s in 2026.

Frequently asked questions

How much does tirzepatide cost per month? It depends on how you buy it. Brand Zepbound's list price is about $1,086/month, LillyDirect self-pay runs roughly $299-$449/month by dose (medication only), and eligible insured patients may pay as little as $25/month with Lilly's savings card. Elara's compounded tirzepatide starts at $355/month, all-inclusive, and works out to about $298/month on the 12-month plan.

Why is tirzepatide more expensive than semaglutide? Tirzepatide is a newer, dual-action molecule that works on two gut-hormone pathways, while semaglutide works on one, and that difference shows up in the price at every tier. At Elara, compounded tirzepatide starts at $355/month versus $247/month for compounded semaglutide. Which one suits you is a clinical decision, not just a price one.

How does compounded tirzepatide compare to Zepbound on cost? Brand Zepbound lists around $1,086/month, though LillyDirect self-pay and insurance savings can lower that. Elara's compounded tirzepatide starts at $355/month, all-inclusive. They are different products, though, Zepbound is FDA-approved for weight management, and compounded tirzepatide is not FDA-approved. The honest comparison is on price and access, not sameness.

What's included in Elara's price? Everything. One all-inclusive price covers the provider visit, the medication, shipping, ongoing access to the medical team after your prescription, the private community, and the app. There is no separate membership fee, and the price doesn't rise as your dose is titrated up over time.

Does insurance cover tirzepatide? Often not for weight loss, and usually not without hurdles. Many commercial plans exclude anti-obesity medications, and traditional Medicare generally hasn't covered them for weight alone. Covered plans often require prior authorization. Elara is cash-pay, so there's no coverage to verify and no denial to appeal, you know the price up front.

The bottom line

Brand Zepbound lists around $1,086 a month, though LillyDirect self-pay and insurance savings can bring that down for some people. Elara's compounded tirzepatide starts at $355 a month, all-inclusive, provider visit, medication, shipping, and support in one transparent price. Compounded medications are not FDA-approved, so talk with a licensed provider about what fits your health and your budget.

References

1. Eli Lilly and Company. Zepbound (tirzepatide) Cost Information, With or Without Insurance. https://pricinginfo.lilly.com/zepbound
2. LillyDirect / Eli Lilly and Company. Zepbound (tirzepatide) Savings & Insurance Options (Self-Pay Pricing). https://zepbound.lilly.com/savings
3. U.S. Food & Drug Administration / DailyMed. Zepbound (tirzepatide) Prescribing Information, Boxed Warning: Risk of Thyroid C-Cell Tumors. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b
4. U.S. Food & Drug Administration. FDA Clarifies Policies for Compounders as National GLP-1 Supply Begins to Stabilize. https://www.fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize
5. U.S. Food & Drug Administration. FDA Proposes to Exclude Semaglutide, Tirzepatide, and Liraglutide on 503B Bulks List (Apr. 30, 2026). https://www.fda.gov/news-events/press-announcements/fda-proposes-exclude-semaglutide-tirzepatide-and-liraglutide-503b-bulks-list
6. Federal Trade Commission. FTC Approves Final Order Against Telehealth Provider NextMed Over Charges It Used Deceptive Advertising Claims to Sell GLP-1 Weight-Loss Programs (Dec. 3, 2025). https://www.ftc.gov/news-events/news/press-releases/2025/12/ftc-approves-final-order-against-telehealth-provider-nextmed-over-charges-it-used-deceptive

This article is for general education and is not medical advice. It doesn't replace a conversation with a licensed clinician about your health, medications, or treatment. Reading it doesn't create a doctor-patient relationship. If you have a medical emergency, call 911. See our full Medical Disclaimer.

Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality.